ZEBRA TECH. A DL-,01/ US9892071054 /
16.05.2024 12:30:35 | Diff. +0,10 | Volumen | Geld13:27:51 | Brief13:27:51 | Marktkapitalisierung | Dividendenr. | KGV |
---|---|---|---|---|---|---|---|
297,10EUR | +0,03% | 0 Umsatz: 0.00 |
297,30Geld Vol: 30 | 299,50Brief Vol: 30 | 15,3 Mrd.EUR | - | - |
GlobeNewswire
14:28
RHR International Partners with SHL to Bring Data Analytics to its Leadership Assessment Solutions
GlobeNewswire
14:15
Hip-Hop Duo Flyana Boss Joins Musicians On Call & Men’s Wearhouse in Making Prom Memories With Pedia...
GlobeNewswire
14:15
Claritas HealthTech Extends Claritas iPET™ capability with iPETcertum™ for Automated Lesion Detectio...
GlobeNewswire
14:15
Imperial Petroleum Inc. Reports First Quarter 2024 Financial and Operating Results
GlobeNewswire
14:05
LED Lighting and EV Charging Solutions Provider Orion Previews FY 2024 Results in Anticipation of it...
GlobeNewswire
14:05
MatrixCare Joins Health Gorilla’s Qualified Health Information Network (QHIN) to Enhance Patient Dat...
GlobeNewswire
14:05
NKGen Biotech Announces Upcoming Presentation on Autologous NK Cell Therapy at the 5th International...
GlobeNewswire
14:03
Meltwater Integrates Influencer Marketing Analytics, Workflows Within Social Suite, in an Industry F...
GlobeNewswire
14:01
Ardelyx Presents Additional Data at the NKF 2024 Spring Clinical Meetings on XPHOZAH® (tenapanor)
GlobeNewswire
14:01
Ocean Biomedical, Inc. (NASDAQ: OCEA) Announces Patent Allowance for Malaria Antibodies That Have Po...
GlobeNewswire
14:00
Fortress Biotech to Participate in the Alliance Global Partners’ (A.G.P.) Virtual Healthcare Company...
GlobeNewswire
14:00
Allegro MicroSystems to Present at TD Cowen’s Technology, Media & Telecom Conference on May 29
GlobeNewswire
14:00
Oragenics, Inc. Prepares Intranasal Pharmaceutical, ONP-002, for Phase II Concussion Trial
- Erste Seite
- Zurück
- 1
- 2
- 3
- 4
- Weiter
- Letzte Seite